Home
Companies
Columbia University

Columbia University

Company

Related News

Multi-Institutional Team Secures $9M Grant to Study Immune Aging in Parkinson's Disease

Jun 19, 2026

A $9 million grant from ASAP and The Michael J. Fox Foundation funds an Indiana University-led study on immune cell exhaustion in Parkinson's disease, aiming to develop personalized immunotherapies. The multi-institutional team will map immune system changes to uncover biomarkers and explain disease heterogeneity. Advances in proteomics are also enabling molecular subtyping and precision medicine across neurological disorders.

Study Links Teen Cannabis Use to Doubled Risk of Bipolar and Psychotic Disorders

Mar 18, 2026

A longitudinal study of 460,000 teenagers found that adolescent cannabis use increases the risk of developing bipolar and psychotic disorders by twofold, as well as raising risks for depression and anxiety.

Acurx Launches Clinical Trial Program for Ibezapolstat in Recurrent C. difficile Infection

Mar 10, 2026

Acurx Pharmaceuticals announced a new clinical trial program for ibezapolstat in patients with recurrent C. difficile infection, building on Phase 2 results showing 96% clinical cure rates with no recurrence while sparing the gut microbiome.

Isomorphic Labs Unveils Proprietary AI Drug Discovery Model IsoDDE

Feb 28, 2026

Isomorphic Labs released a 27-page technical report on IsoDDE, its new AI drug-discovery engine that outperforms existing models in predicting drug-protein interactions and antibody structures, but the proprietary system offers limited technical details.

SSRI Use in Pregnancy Linked to Gestational Diabetes Risk but Protects Against Preterm Birth

Feb 14, 2026

A population-based study of over 1.27 million births found SSRI antidepressants during pregnancy increase gestational diabetes risk but reduce preterm birth and low birth weight risks, with effects independent of maternal depression.

RFK Jr. Claims Keto Diet Cures Schizophrenia; Experts Dispute Assertion

Feb 10, 2026

U.S. Health Secretary Robert F. Kennedy Jr. claimed ketogenic diets can cure schizophrenia, but psychiatry experts say the assertion goes far beyond what current scientific evidence supports.

Related Clinical Trials

NCT ID	Title	Status	Phase
NCT07610590	guideSEQ: Genomic Understanding, Impact, Decision & Ethics in Prenatal Sequencing	RECRUITING
NCT07607665	Spinal Cord Associative Plasticity in Cerebral Palsy	RECRUITING	NA
NCT07603245	Multidimensional Sleep Health Intervention for Couples	NOT_YET_RECRUITING	NA
NCT07594730	RCT of Brief Intervention Addressing Stigma Among Parents of Children With Mental Health Problems	NOT_YET_RECRUITING	NA
NCT07582211	Bilevel Positive Airway Pressure (BPAP) for Severe Asthma	NOT_YET_RECRUITING	NA
NCT07567794	GBPDC: Gut-Brain in PD Consortium Master Protocol	NOT_YET_RECRUITING
NCT07567495	Adding Dexmedetomidine or Clonidine to Spinal Anesthesia for Cesarean Delivery	NOT_YET_RECRUITING	PHASE4
NCT07564583	Pilot Study of a Modified Safety Planning Intervention for Elementary School-Aged Children - Main Study	ENROLLING_BY_INVITATION	NA
NCT07561372	Adaptive Recruitment Curve Analysis Using Bayesian Modeling	NOT_YET_RECRUITING	NA
NCT07559955	Adapting Youth Nominated Support Team (YST) to Prevent Suicide	RECRUITING	NA